Selection of a validated scale for measuring medication adherence

Journal of the American Pharmacists Association

Volumn 51, Issue 1, 2011, Pages 90-94

  Lavsa, Stacey M ^a   Holzworth, Ashley ^b   Ansani, Nicole T ^c,d  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c PFIZER INC   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adherence (medication); Questionnaires; Self management; Surveys

Indexed keywords

BRIEF MEDICATION QUESTIONNAIRE; HEALTH BEHAVIOR; HEALTH SURVEY; HILL BONE COMPLIANCE SCALE; HUMAN; HYPERTENSION; INTERNAL CONSISTENCY; MEDICATION ADHERENCE QUESTIONNAIRE; MEDICATION ADHERENCE RATING SCALE; MEDICATION COMPLIANCE; PATIENT CARE; QUESTIONNAIRE; RATING SCALE; RELIABILITY; REVIEW; SCORING SYSTEM; SELF EFFICACY FOR APPROPRIATE MEDICATION USE SCALE; SELF REPORT; SENSITIVITY AND SPECIFICITY; PATIENT COMPLIANCE;

HUMANS; MEDICATION ADHERENCE; QUESTIONNAIRES;

EID: 79955942432     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2011.09154     Document Type: Review

References (25)

1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-97.
2. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002;36:1331-6.
3. Schiff GD, Fung S, Speroff T, McNutt RA. Decompensated heart failure: symptoms, patterns of onset, and contributing factors. Am J Med. 2003;114:625-30.
4. Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm. 2001;58:1126-32.
5. Miura T, Kojima R, Mizutani M, et al. Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study. Eur J Clin Pharmacol. 2001;57:77-83.
6. American Heart Association. Heart disease and stroke statistics: 2008 update. Dallas, TX: American Heart Association; 2008.
7. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
8. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10:348-54.
9. Risser J, Jacobson TA, Kripalani S. Development and psychometric evaluation of the Self-efficacy for Appropriate Medication Use Scale (SEAMS) in low-literacy patients with chronic disease. J Nurs Meas. 2007;15:203-19.
10. Svarstad BL, Chewing BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37;113-24.
11. Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs. 2000;15:90-6.
12. Krousel-Wood M, Muntner P, Jannu A, et al. Reliability of medication adherence measure in an outpatient setting. Am J Med Sci. 2005;330:128-33.
13. Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000;42:241-7.
14. Fialko L, Garety PA, Kuipers E, et al. A large-scale validation study of the Medication Adherence Rating Scale (MARS). Schizophr Res. 2008;100:53-9.
15. Hahn SR, Park J, Skinner EP, et al. Development of the ASK-20 Adherence Barrier Survey. Curr Med Res Opin. 2008;24:2127-38.
16. Elm JJ, Kamp C, Tilley BC, et al. Self-reported adherence versus pill count in Parkinson's disease: the NET-PD experience. Mov Disord. 2007;22:822-7.
17. Afonso NM, Nassif G, Aranha AN, et al. Low-density lipoprotein cholesterol goal attainment among high-risk patients: does a combined intervention targeting patients and providers work? Am J Manag Care. 2006;12:589-94.
18. George CF, Peveler RC, Heilinger S, Thompson C. Compliance with tricyclic antidepressants: the value of four methods of assessment. Br J Clin Pharmacol. 2000;50:166-71.
19. Gao X, Nau DP. Congruence of three self-report measures of medication adherence among HIV patients. Ann Pharmacother. 2000;34:1117-22.
20. Shalansky SJ, Levy AR, Ignaszewski AP. Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother. 2004;38:1363-8.
21. Krass I, Taylor SJ, Smith C, Armour CL. Impact on medication use and adherence of Australian pharmacists' diabetes care services. J Am Pharm Assoc. 2005;45:33-40.
22. Rickles NM, Svarstad. Relationships between multiple self-reported nonadherence measures and pharmacy records. Res Social Adm Pharm. 2007;3:363-77.
23. Cook CL, Wade WE, Martin BC, Perri M. Concordance among three self-reported measures of medication adherence and pharmacy refill records. J Am Pharm Assoc. 2005;45:151-9.
24. Nguyen GC, Laveist TA, Harris ML, et al. Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:1233-9.
25. Rosa AR, Marco M, Fachel JM, et al. Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:217-24.